Mutual of America Capital Management’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
GIPM
AC
AIC
FLAM
CS
Mutual of America Capital Management's OPRX Position: Q4 2022 in Review
Mutual of America Capital Management sold out of OptimizeRx (OPRX) in Q4 2022, closing a stake of 3,587 shares — an estimated $53K sold.
Mutual of America Capital Management first reported a position in OPRX in Q4 2021 and held it in 4 quarters. The position peaked at $151K in Q4 2021. 129 funds tracked by Wall St. Rank hold OPRX as of Q4 2022.
- Mutual of America Capital Management reported no remaining OptimizeRx position as of Q4 2022 after selling out during the quarter.
- Mutual of America Capital Management sold 3,587 OptimizeRx shares in Q4 2022, an estimated $53K.
- Mutual of America Capital Management first reported a position in OptimizeRx in Q4 2021 and held it in 4 quarters.
- Mutual of America Capital Management's OptimizeRx position peaked at $151K in Q4 2021.
- 129 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2022.
Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.